Applied Therapeutics (APLT) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Applied Therapeutics Revenue Highlights


Latest Revenue (Y)

$9.99M

Latest Revenue (Q)

$190.00K

Main Segment (Y)

License

Applied Therapeutics Revenue by Period


Applied Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$9.99M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Applied Therapeutics generated $9.99M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Applied Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31$190.00K-128.49%
2023-12-31$-667.00K100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$10.66M100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Applied Therapeutics generated $190.00K in revenue during Q1 2024, up -128.49% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Applied Therapeutics Revenue Breakdown


Applied Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
License$9.22M
Research and Development Services$774.00K

Applied Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (92.25%), and Research and Development Services (7.75%).

Quarterly Revenue by Product

Product/ServiceMar 24
Research and Development Services$190.00K

Applied Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Research and Development Services (100.00%).

Applied Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
HOOKHOOKIPA Pharma$20.13M-
SEERSeer$16.66M$3.07M
APLTApplied Therapeutics$9.99M$190.00K
MOLNMolecular Partners$7.04M$2.74M
STTKShattuck Labs$1.66M$1.61M
LYRALyra Therapeutics$1.56M$598.00K
TFFPTFF Pharmaceuticals$733.87K$650.22K
LIFEaTyr Pharma$353.00K$235.00K
GANXGain Therapeutics$55.18K-
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
XFORX4 Pharmaceuticals-$563.00K
BCABBioAtla--
DAWNDay One Biopharmaceuticals-$20.07M
INABIN8bio--
TERNTerns Pharmaceuticals--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
VINCVincerx Pharma--
ORICORIC Pharmaceuticals--
LTRNLantern Pharma--

APLT Revenue FAQ


Applied Therapeutics's yearly revenue for 2023 was $9.99M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. APLT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Applied Therapeutics's quarterly revenue for Q1 2024 was $190K, a -128.49% decrease from the previous quarter (Q4 2023), and a -98.22% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $-667K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). APLT's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

Applied Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

Applied Therapeutics's revenue streams in c 23 are License, and Research and Development Services. License generated $9.22M in revenue, accounting 92.25% of the company's total revenue Research and Development Services generated $774K in revenue, accounting 7.75% of the company's total revenue

For the fiscal year ending Dec 23, the largest source of revenue of Applied Therapeutics was License. This segment made a revenue of $9.22M, representing 92.25% of the company's total revenue.